Replies to post #11505 on Amarin Corp Plc (AMRN)

[1millman]

I don't think they would accept a $15 offer. ANCHOR has 10X the market potential than MARINE does and MARINE's main competitor sells 1B per year and it is an inferior drug. Manipulation of this stock has presented a very good opportunity to load up on cheepies IMO. I think if ANCHOR gets approved and sales start coming in strong, BP will be fighting for it for $25 or more.

[BaaBaa45]

$15 per share.....no chance. AMRN management would not sell for double that.

[james murphy]

Gotta face reality its $5 so 300% sale good to me

[sts66]

ELN didn't really sell for $16/shr - they have $3.66/shr in cash, so the real price was $12.34/shr, a tad higher than Royalty Pharma's $13/shr cash offer, which was of course also only a bid of $9.64/shr.